Insulin Glargine News
Links shared publicly online about this topic
Insulin use linked to lung cancer risk in diabetes
news-medical.net — “Postmenopausal women with treated diabetes may be at an increased risk for lung cancer, particularly if they are on insulin, say researchers.” View full resource at news-medical.net
Most Recently Shared on May 30, 2012 at 11:32 pm By:
News-Medical.Net Oncology and Health News
Oncology News: Insulin use linked to lung cancer risk in diabetes: Postmenopausal women with treated diabetes ma... http://t.co/zCeI2vea
Impaired brain insulin action may worsen type 2 diabetes
news-medical.net — “Researchers from Mount Sinai School of Medicine have discovered a novel function of brain insulin, indicating that impaired brain insulin action may be the cause of the unrestrained lipolysis that initiates and worsens type 2 diabetes in humans. The research is published this month in the journal Cell Metabolism.” View full resource at news-medical.net
Most Recently Shared on February 17, 2011 at 7:49 am By:
Diabetes News: Impaired brain insulin action may worsen type 2 diabetes: Researchers from Mount Sinai School of ... http://bit.ly/e8uCzX
Hygieia's DIGS Automatic Insulin Titration Device Shows Promise; Company Talks to Medgadget
medgadget.com — “An experimental new device called Diabetes Insulin Guidance System (DIGS) from Hygieia, Inc. (Ann Arbor, MI) is being developed to automate insulin dosage” View full resource at medgadget.com
Most Recently Shared on May 18, 2012 at 5:44 pm By:
[News] Hygieia’s DIGS Automatic Insulin Titration Device Shows Promise; Company Talks to Medgadget http://t.co/aPPaA4XS #medicaldevice
Pfizer scraps insulin deal with India's Biocon - Yahoo! News
news.yahoo.com — “From Yahoo! News: MUMBAI (Reuters) - Pfizer Inc, the world's largest drugmaker, has scrapped a deal to sell insulin products made by Biocon Ltd, leaving India's biggest biotechnology company without a partner to sell the drugs in key markets such as the United States. Pfizer cited other priorities in its biosimilar program for the split, which immediately ends a relationship that stood to earn Biocon hundreds of millions of dollars in royalties. Shares of Biocon fell 6.3 percent. ...” View full resource at news.yahoo.com
Most Recently Shared on March 13, 2012 at 3:35 am By:
HealthTrendster Health Executive
Pfizer scraps insulin deal with India's Biocon - (Reuters) - Drugmaker Pfizer said on Monday it has scrapped a deal ... http://t.co/TSjPROke
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
News-Medical.Net
Stay up to date with the latest Oncology news and research via News-Medical.Net
-
News-Medical.Net
Stay up to date with the latest Diabetes news and research via News-Medical.Net
-
Medgadget
Medical technology news from around the world.
Advertisement
